関連する実験動画
Updated: Jan 8, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
ポリコンブ群のタンパク質EZH2は,DNAメチル化を直接制御する
Emmanuelle Viré1, Carmen Brenner, Rachel Deplus
1Free University of Brussels, Faculty of Medicine, Laboratory of Molecular Virology, 808 route de Lennik, 1070 Brussels, Belgium.
Nature
|December 17, 2005
まとめ
ポリコンブ群 (PcG) タンパク質とDNAメチレーションは,重要な表遺伝的静音化システムである. この研究は,EZH2タンパク質がこれらの経路をリンクし,遺伝性遺伝子抑制のための標的遺伝子をDNAメチルトランスファーゼに勧誘することを明らかにしています.
科学分野:
- エピジェネティクス エピジェネティクス
- 分子生物学は分子生物学である.
- 遺伝子規制 遺伝子規制
背景:
- エピジェネティック遺伝子サイレンシングは,細胞のアイデンティティと機能にとって極めて重要です.
- ポリコンブ群 (PcG) タンパク質とDNAメチレーションは,遺伝性遺伝子抑制の主要なシステムである.
研究 の 目的:
- PcGタンパク質とDNAメチル化経路のメカニズム的な関連性を調査する.
- これらの2つのエピジェネティック抑制システムを接続するEZH2の役割を決定する.
主な方法:
- EZH2とDNAメチルトランスファーゼ (DNMTs) の関連性に関するin vivo研究.
- クロマチン免疫プレシピテーション測定法では,DNMTがEZH2調節遺伝子に結合することを評価します.
- 標的プロモーターにおけるDNAメチレーションを評価するためのビスルファイトゲノムシーケンシング.
主要な成果:
- EZH2はDNMTと相互作用し,DNMTの活性に関連しています.
- EZH2抑制遺伝子へのDNMT結合は,EZH2の存在に依存しています.
- EZH2は,標的遺伝子プロモーターのDNAメチル化に不可欠です.
結論:
- EZH2は,特定の遺伝子の位置にDNMTを勧誘して,支架として機能します.
- PcGタンパク質媒介による遺伝子静止とDNAメチル化媒介による遺伝子静止の間の直接的なメカニズム的なリンクが確立されています.
- この発見は,2つの基本的な表遺伝的調節経路の間の新しいつながりを明らかにします.
関連する概念動画
Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K